-transparent.png){kind=logo}
Dispersed corticotrophic cells of 3 patients with Nelson's syndrome were studied in tissue culture for up to 25 days. During this culture period a parallel decrease with time was seen in ACTH and beta-endorphin-like immunoreactivity ( LIR ) release. A concomitant decline was observed for intracellular hormones. The time course of hormone release showed a parallel secretion of ACTH and beta-endorphin- LIR up to 8 h. Both the release of ACTH and beta-endorphin LIR were stimulated by 0.1 microM lysine vasopressin (LVP) in all three adenoma cell cultures. Dexamethasone (0.1 and 1 microM) suppressed basal hormone secretion for 4 h. Synthetic ovine corticotrophin-releasing factor (CRF) at 10 and 100 nM stimulated the secretion of ACTH and beta-endorphin LIR maximally. This stimulation was higher than observed with maximal stimulative concentration of LVP (0.3 microM). The CRF-mediated hormone secretion was calcium-dependent. Dexamethasone (0.1 microM) blocked the stimulating effect of 10 nM CRF completely. Gel-filtration chromatography demonstrated the cells to secrete both beta-lipotrophin (beta-LPH) and beta-endorphin. The ratio of beta-LPH to beta-endorphin released remained constant upon stimulation by LVP and CRF. HPLC studies demonstrate the possibility that several beta-endorphin fragments, including alpha-endorphin and gamma-endorphin, were secreted by cells from a Nelson tumour. CRF caused a simultaneous parallel stimulation of the release of these peptides.
R Oosterom, and
T Verleun, and
P Uitterlinden, and
W H Hackeng, and
J P Burbach, and
V M Wiegant, and
S W Lamberts
January 1986,
Neuroendocrinology,
R Oosterom, and
T Verleun, and
P Uitterlinden, and
W H Hackeng, and
J P Burbach, and
V M Wiegant, and
S W Lamberts
January 1983,
Life sciences,
R Oosterom, and
T Verleun, and
P Uitterlinden, and
W H Hackeng, and
J P Burbach, and
V M Wiegant, and
S W Lamberts
March 1989,
The Journal of endocrinology,
R Oosterom, and
T Verleun, and
P Uitterlinden, and
W H Hackeng, and
J P Burbach, and
V M Wiegant, and
S W Lamberts
March 1998,
European journal of endocrinology,
R Oosterom, and
T Verleun, and
P Uitterlinden, and
W H Hackeng, and
J P Burbach, and
V M Wiegant, and
S W Lamberts
August 1989,
Clinical endocrinology,
R Oosterom, and
T Verleun, and
P Uitterlinden, and
W H Hackeng, and
J P Burbach, and
V M Wiegant, and
S W Lamberts
September 1992,
Neuroendocrinology,
R Oosterom, and
T Verleun, and
P Uitterlinden, and
W H Hackeng, and
J P Burbach, and
V M Wiegant, and
S W Lamberts
August 1994,
European journal of endocrinology,
R Oosterom, and
T Verleun, and
P Uitterlinden, and
W H Hackeng, and
J P Burbach, and
V M Wiegant, and
S W Lamberts
April 1976,
Endocrinology,
R Oosterom, and
T Verleun, and
P Uitterlinden, and
W H Hackeng, and
J P Burbach, and
V M Wiegant, and
S W Lamberts
January 1992,
Journal of neural transmission. General section,
R Oosterom, and
T Verleun, and
P Uitterlinden, and
W H Hackeng, and
J P Burbach, and
V M Wiegant, and
S W Lamberts
November 1983,
The Journal of clinical endocrinology and metabolism,
